Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Syndecan-4 as a Biomarker for Determining Patients Prognosis With Chagas Disease.

NCT01842867 is registered in ClinicalTrials.gov with Hospital Sao Rafael as lead sponsor.

NCT NCT01842867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01842867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Syndecan-4 as a Biomarker for Determining Patients Prognosis With Chagas Disease.
Lead sponsor
Hospital Sao Rafael
Phase
Observational
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2015
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chagas disease